MARKET OVERVIEW:

The global potassium citrate market, valued at USD 777.9 million in 2024, is expected to grow at a compound annual growth rate (CAGR) of 3.36% from 2025 to 2033. Key growth drivers include its widespread use in the food and beverages sector for enhancing flavor and shelf life, as well as increasing demand in the pharmaceutical industry for treating kidney stones and urinary tract infections. Additionally, the growing popularity of processed foods and dietary supplements is propelling market expansion.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019-2024
• FORECAST YEAR: 2025-2033

POTASSIUM CITRATE MARKET KEY TAKEAWAYS:

• The global potassium citrate market size was USD 777.9 million in 2024 and is forecast to reach USD 1,047.4 million by 2033.
• The market is expected to grow at a CAGR of 3.36% from 2025 to 2033.
• Rising demand from the food and beverages industry for flavor improvement and shelf stability is driving market growth.
• Increasing use in pharmaceuticals, particularly for kidney stones and urinary tract infections, is enhancing market prospects.
• Asia-Pacific is the dominant region due to rising consumption in food and pharmaceutical sectors.

MARKET GROWTH FACTORS:

Recent Developments in Technologies That Are Applied to Food Processing:
Such technological advances in food processing have increased demand for potassium citrate. The compound is fastly taking ground about its increasing applications in augmenting taste, texture, and shelf-life in processed foods. Other factors which continue to drive demand include manufacturers wanting to use potassium citrate as an enhancer for food-quality-improving additive as there is a global demand of USD 181.5 billion for ready-to-eat foods in 2023. One more requirement in shifting faster toward healthier low-sodium substitutes is obviously the use of potassium citrate, since consumers now opt to ensure food stability without losing nutritional value.

Emergence of the Pharmaceutical Industry:
The applications of potassium citrate in pharmaceuticals are highly related to the treatment of kidney stones and urinary tract infections (UTIs). An alkalizing agent keeps the pH of the urine alkaline and, consequently, potassium citrate is way important for managing metabolic acidosis as well as stone formation prevention in the kidney. The presence of these conditions increases the prevalence of chronic kidney diseases and urinary disorders all over the world and thus plays a significant role in enhancing the growth of potassium citrate medicines. Their application in the pharmaceuticals, therefore, is greatly conditioned on the different alternatives available for drug formulation and modes of new delivery.

Growing Health Awareness and Requirement of Supplements:
Growing health awareness among consumers creates a demand for potassium citrate dietary supplements. Potassium citrate found its own market upsurge in the wellness domain because of its kidney health improvement and stone prevention properties. Emerging lifestyle diseases such as hypertension and obesity increase the number of people maintaining preventive health goals through the consumption of dietary supplements. Over time, demand for potassium citrate dietary supplements will continue to endow infinite ramifications as public awareness regarding healthy mineral balance heightens. This factor will further serve in a good way in spurring market growth.

Request Sample For PDF Report: https://www.imarcgroup.com/potassium-citrate-market/requestsample

Market Segmentation:

Breakup by Type:

• Monohydrate
• Anhydrous

Breakup by Function:

• Acidulant
• Emulsifier
• Stabilizer
• Antioxidants
• Others

Breakup by End User:

• Food and Beverages
• Pharmaceuticals
• Personal Care
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

KEY PLAYERS:

• Archer-Daniels-Midland Company
• ATPGroup
• Cargill Incorporated
• Dr. Paul Lohmann GmbH & Co. KGaA
• FBC Industries
• Foodchem International Corporation
• Gadot Biochemical Industries Ltd.
• Huangshi Xinghua Biochemical Co. Ltd.
• Jiangsu Mupro IFT Corp.
• Jungbunzlauer Suisse AG
• Niran BioChemical Limited
• RZBC Group Co. Ltd.
• Tate & Lyle PLC

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.